BioHealth News Archive
New bio-incubator and life-science accelerator capability launches at Babraham – Cambridge Network
Accelerate@Babraham is designed to support the earliest stages of new life-science ventures, by providing easy-access laboratory and office space, (the ‘bio-incubator’) together with supporting…
Read More
ETC’S ACCELERATE BALTIMORE ANNOUNCES APPLICATIONS ARE OPEN FOR THE SEVENTH YEAR OF ITS SEED STAGE ACCELERATOR — Accelerate Baltimore
The ETC (Emerging Technology Centers), Baltimore City’s award-winning technology and innovation centers, announces the Accelerate Baltimore (AB) program will run for its seventh consecutive…
Read More
Startups: One Entrepreneur’s View of Balancing Passion with Practicality | UM Ventures
Richard Hughen’s first entrepreneurial experience was as Managing Director at e-learning startup LearnWare, where he says his “addiction” to startups began in earnest. The…
Read More
California Life Sciences Association Applauds Confirmation of Alex Azar as HHS Secretary – Business Wire
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today commended the U.S. Senate’s confirmation of Alex M. Azar, II…
Read More
Paragon Bioservices aims to create 200 jobs with Maryland expansion – Technical.ly Baltimore
Paragon Bioservices has plans to expand to new space over the next two years to help companies develop and manufacture biopharmaceuticals. {iframe}https://technical.ly/baltimore/2018/01/23/paragon-bioservices-aims-create-300-jobs-maryland-expansion/{/iframe}
Read More
Johns Hopkins U creates new test to screen for 8 cancers – WBFF
Researchers with the Johns Hopkins University School of Medicine developed a new blood test able to screen for eight types of cancers. {iframe}http://foxbaltimore.com/news/local/johns-hopkins-u-creates-new-test-to-screen-for-8-cancers{/iframe}
Read More
Regenxbio (RGNX) Enters Strategic Partnership with FUJIFILM Diosynth Biotechnologies
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
New York sketches out $500M plan to build a biotech hub – FierceBiotech
New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The…
Read More
Startup fundraising and exits look bullish for bio and health | TechCrunch
After nearly a year, venture capitalists nabbed their first U.S. acquisition for more than a billion dollars. And it wasn’t a tech startup. Nor…
Read More
Accelerate Baltimore – Join 6 startups on a unique mission to success
Accelerate Baltimore™ is an initiative of the ETC (Emerging Technology Centers), Baltimore’s award winning incubator, and The Abell Foundation. In its first six years,…
Read More
Paragon Bioservices Announces New Commercial Manufacturing Facility Expansion
Paragon Bioservices (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces…
Read More
Anatomy of two biotech deals worth $20B – MedCity News
Analysts had forecast a blockbuster year for life science mergers and acquisitions as the lower tax rate for repatriated cash kicks-in and Big Pharma…
Read More
Venture capital vital to future of biotech – Laboratory News
The Association of the British Pharmaceutical Industry has released a report suggesting that pharma companies investing in emerging start-ups is now a key source…
Read MoreWhat’s the reaction to Gov. Larry Hogan’s proposed incentives for Amazon? – The Washington Post
Maryland Senate President Thomas V. Mike Miller Jr. (D-Calvert) and Democrats from Montgomery County are rallying around Republican Gov. Larry Hogan’s $5 billion incentive package…
Read More
HHS issues Four (4) PHS 2018-2 SBIR and STTR Omnibus/Parent Grant Solicitations with FORMS-E and Clinical Trials Policy Updates
2018 SBIR and STTR Omnibus/Parent Grant Solicitations for the NIH, CDC, and FDA, Clinical Trial Not Allowed and Clinical Trial Required SBIR Omnibus/Parent Clinical…
Read More